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S in ce th e biochemi ca l events kadin g to cut:lllco u s infl am-
ma tion in ;Hopic derm atiti s and psoriasis arc unknown , we 
s tudied the levels of a rachidon ic acid-deri ved m edi a to rs of 
inflammation as well ::ts hi stami ne in th e su ct io n b li s ter Auid 
obta ined from lcs io n al and n o n lcsiona l skin of pa ti en ts w ith 
these d e rm::t toses. Mediato r levels w~.: re determined ra-
dioimmunologi ca ll y . Skin fro m hea lth y contro ls an d un -
involved sk in fro m p at ie nts contained very low o r un -
meas ura ble leve ls of the 5- li poxygenJsc m etabo lite of 
a rachidon ic acid , lcukotri e ne (LT) B 4 . In contrast, hi g h e r 
leve ls of L TBrli ke i 111111 un o reacri v it y were detected in su c-
t ion bl iste r fl uid from lcs io n ::li atop ic dermatitis sk in , and 
even hi g her con centratio n s occurred in p so ri as is les io n s. 
L TBrlike immun o reacti v it y from a topic d e rm a titis su c-
tion blister fluid cochro matographed o n reverse-phase hi g h-
pressure liqu id ch romatography with authenti c L TB.~o th u s 
ex clud in g c ross-reactio n of the L TB.cann body w ith arach-
idon ic ac id o r m o n o h ydroxyc icos:t tctracn o ic acid s. Jn con-
T he biochemica l eve1Hs un de rl yin g infhmmatory chan ges in atopic derm atiti s sk i.n arc unkn own. Sine. e itch is a predon 11nan t sympto m o f th is chsease . hi s-tam ine in vo lve m ent has becn suspected 11.2 1. Anti-histan lines, however , display o nl y wea k therapeuti c 
activit y in this di sease. In co ntra st, the therapeuti c efficiency of 
g lucoco rri costero ids in atop ic dermatitis must be taken into CO il-
sideration w hen interpreti ng resu lts from studies co ncerned wit h 
pathobiochemistry of the disease . Recentl y, arachid o nic acid-
derived mediators o f infl amm ationevo lved :1s potentia l ca ndidates 
ro ass ume :1 pathogeneti c role in cutan eous inflamm ation due to 
rheir po tent proinflamn1Hory act ivities (rev iewed in . 131). Tl11 s 
assumption is st rengt hened by the fact that g lu coco rtJ costerOids 
suppressed in in-vitro studies bo th cyclooxygenase an d li poxy-
gcnase products of ara chidon ic acid metabo li sm via indirect in-
hibitio n of the enzy m e phospho li pase A ~ 1·+1-
M ew bolic transfo r111 .1tio 11s of arachidoni c K id ca n proceed along 
severa l pathways. Cyclooxygenase path way leads to the forma-
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Abbn;viations: 
12-H ETE: 12-hydroxycicosarct racnoic Kid 
HI'L C: hig h-pr~ssun· liq uid chrou1arograp hy 
ir: inl11lli 11 0 rl';1 Ctive 
L T: lcukotri cnc(s) 
I'G: prostag la11 din 
tr:1st. su cti o n b li ster con centrat ions of the cyclooxygen ase 
metaboli te of arachido nic acid prostaglandin (PG) E2 showed 
n o s ig nifi c:m t diffe ren ces between lcsional Jnd n o n lcsional 
patiem skin and h ea lt h y contro l ski n. PGD 2 determi ned as 
a stab le m etabolite co ul d n ot be detected in th ese sa mples. 
Histam in e co n centrat io n s in lesion al skin were w ithin n o r-
m a l ran ge. The elevated levels of th e poten t proinflam-
m :Jtory and immunomodula ting m ed iator LTB_1 cou ld be 
invo lved in the pathogenes is of c uta neo us inflammation in 
a topi c dermatitis and pso ri asi s. In additio n , they mig ht 
exp lain the th e rapeutic efficien cy of g lucoco rticosteroids , 
wh ic h a m o n g o ther act io ns inhibit the release of arachi-
don ic acid fro m phosph o lipid stores by b lockin g th e e n-
zy m e phos pho li p:t se A 2 . However, the specificity of disease 
expression in atop ic dermatitis a nd psorias is must be due 
to b cto rs o ther tha n cuta neous L TB.1 elevatio n. J ln 11csr 
Dcnnaro/86·105-108, ·J986 
ti o n of, am o ng others, classi a! prostagla ndi ns (I'G) such as PGE~ , 
w hi ch has been identified as the major cycloox ygcnasc product 
in h um an skin 15 1. Alternati vely, arachid o ni c acid ca n be nl ctab-
o lized by lipoxygcnases , of w h ich 5-li poxygenase llJ s attracted 
particular interest due to its fo rmatio n o( subst:111ces with ex-
tremely potellt biolog ic act ivit ies, th e kukotri enes (L T ). 5-Li-
poxygc n:Isc enzy m e activ it y h:~ s also bee n identified in epidermis 
In I. WL· therefore decided to in vestigate cutaneous levels of ar-
achid onic acid-deri ved m ed iato rs of infl ammati on in atop ic der-
rnatiti s skin. We mcasun:d the CO IJCelltr·atio ns of the m:~i n cy-
clooxygc nase metabo li tes I 'GE~ :md I'GD~ . the 5-lipoxygc n:lse-
derived product L Tl3 . ., and in additi o n hi sta m ine in suctio n b lister 
fluid obta in L·d from lcsiona l :md nonlcsiona l :~topic dermatitis skin. 
l ~esu l t s we re compared with th ose measured in anoth er inflam-
matory dnm:~ tosis. pso rias is. !'art o( these rL'Stdts was published 
in a prel im inary commun ication 17 1. 
MATER IALS AND METHODS 
Patien ts, Suction Blisters Sixteen p:1tients w ith atopic der-
nntitis, aged 13-6') years , 1-l m :ll L' and R female, were studi ed. 
Diagnosis was made :~ccord in g to 1-bnifin and fbjb 18 1. The 
psorias is g roup co mprised 9 p:Hients aged I S-78 yea rs. 6 m ale 
and 3 fem :~ l e. Six of these p:1tien ts suffered fro m chronic pbq ue 
type psoriasis, 2 paticm s had crythrodcrmi c d isease . 1 patient 
showed pso riasis g utt:na. Twelve vo luntee rs aged 21-72 yea rs, (i 
lll~k and (, Cemak, were used as co ntrols. All pro bands were 
without an y medi catio n fo r :n lea st 14 d:1ys. Som e of the atopic 
derm:nitis subjects used top ical em o ll ients up to the l'Vening be-
fore ex:~ min at i on. Suct io n blisters wne raised usin g the Der-
mova c suction blistn ck vice r9 1. In atopic dermatitis subjects. 
suctio n blistns were raised o n clini ca ll y most affected ;n cas, usu-
.1 11 )' in rhe antecubital fossa. T he cczcm:n o us les ions sa m pled wnc 
OU22-202X / i:l(>/$03.50 Copyright 1D I<Ji'l(> by The Society to r ln vcsri g:~ tivc Dcnmtology, Inc. 
105 
106 RUZICKA ET AL 
usuall y of the acute , inflammato ry typt:. In ecze m atous sk in , intact 
blistt:rs were no t always o btained and, in thest: cases, interstitial 
fluid was co llected fro m the vacuum bell o f the dev ice. Contro l 
b listers were takt:n fro m clini ca ll y unin vo lved skin , usual ly in th e 
periumbilica l area. Correspo ndin g a reas we re chosen in tht: con-
trol subj ects. The bliste r fluid was removed , immedi ate ly frozen 
in liquid nitrogen , and sto red at -70°C until assay . 
lb di o immunoassays ofarach idonate metabo lites J> GE 2, PGD2 , 
and LTI3.1 we re determin ed radi o immuno logica ll y in unextrac tcd 
blister fluid s. T he deta ils o f th e radio immunoassay fo r PGE~ have 
been described previous ly [1 0,11 1. PG D~ is unstable in th e pres-
Cil ce of a lbumin 11 2 1 and was , therefore, determined after con-
version to a stable deg radation produ ct 11 3 1. 
The an t i-L Tl3 4 antiserum 11 4.1 w as obtained fro m Wcllco me 
Diagnos ti cs, 1. \cckenham, Kent, U.K.[5,6,H,<J, I1, 12.14,15J.I (n)-
3HIL TB.1 (sp act 32 C i/ mm o l) was purchased fr o m Amersham 
In ternationa l. 
Further confirmation of the identit y of the immunorea cti ve 
L Tl34 in suct ion bli ste r Huid from atopic derm atitis patients w:1s 
obtained by hi gh-pressure liquid chro matograp hic (HPLC) sep-
arat io n o f the s:1 mplcs prior to rad io immunoassay. HPLC w:1s 
performed acco rdin g to Fitzpatri ck er :II 11 5 1 . .l3rieHy, 4 sa mp les 
of suctio n blister fluid from invo lved atop ic derm atiti s skin con-
tainin g L TB4- Iik e immuno reacti v ity we re poo led. yielding a vo l-
um e of approximately I mi. The poo led sa mple was brought up 
to 10 ml with 0 .01 M Tri s/ 1-J C I buffe r. pH 7.4. and acidifi ed to 
pH 3.0. The sa mple was applied to a C IR-Sep i'ak co lumn (Waters) 
conditio ned sequentiall y w ith 20 m l t: th ano l, 20 ml 1-1 ~0. and 5 
ml 0.01 M Tris/H C I b uffer , pH 3.0. The sa mple was eluted w ith 
I 0 ml hexa ne, then w ith 8 ml m ethy l fo rm ate (thi s frac ti on co n-
tai ns L TB.1), and finally with 5 mlm eth ano l (thi s frac tio n co ntains 
the sulfid o peptide lcuk o trien es). The meth yl-formate fract io n was 
evaporated, redis solved in methan o l, and inj ected on a C 18-Nu-
cleosil co lumn (M achcrey-Nagcl , J)(ircn ). The mo bile phase con-
sisted of meth ano i:H 20 :acc ti c ac id 6B:32:0. 0 I . pH 5.5. O ne-mi lli -
liter fr ac tions we re ·co ll ectcd and tes ted for the prese nce of im-
mun o reacti ve (ir) LTB by radi o immunoassay. 
Hista1nine Assay Hi stamine in suctio n bli ste r Huid was deter-
min ed usin g a radi oenzy m ati c assay acco rdin g to Beaven ct al 
11 61. 
Serum Immunoglobulin E Determination Serum IgE was 
measured by a paper-radio-immuno-sorbent- tcs t (PHI ST) (PilJr-
m acia, Uppsa la). 
RE S ULTS 
Skin Levels of L TB4-Like Immunoreactivity (Fig 1) The 
level s of L TTI.1-l ik e immuno reacti vit y in suction blisters rai sed o n 
skin of hea lthy probands were no t m easurable o r were ve ry low. 
In 7 of'J sa mples fro m antecubital skin and 10 of 12 s:11nplcs fro m 
abdomi nal skin , ir L TB4 was below th e detec ti on limi t of ·194 
pg/ ml. In onl y 2 sampl es fro m each loca ti on , low ir L TB, leve ls 
co uld be detected (197-268 pg/ ml ). Likewise, in H o f 13 sa mples 
fro m unin volved atopic derm atitis sk in , ir L T l34 was undetect-
able . The va lu es in the rema inin g 5 sa mp les wert: !99. 2B3. 2<J I. 
299, :md 38R pg/ ml , respecti vely . The m ea n ± SEM value was 
23 1 ± 62 pg/ ml. Fo r this ca lcubtion. the va h1 t: of J<J4 pg/ ml was 
assu med in case o f undetectable le vels , a method w hi ch probab ly 
overestimates the m ea n va lue. In sharp contrast , mark edl y ele-
vated ir L Tl3.1 co ncentrati ons we re fo und in lcsio nal skin fro m 
ato pi c dermatitis pati en ts. O nl y 5 of ·16 sa mpl es contain ed no 
meas urabl e ir L TB.1. The remainin g va lues ran ged up to 1524 
pg/ ml , the mea n ± SE M va lu e was 426 ± H5 pg/ ml. The dif-
ferm ce between lcsio nal and no nlcsional atopic derm atit is skin 
was stati s ti ca ll y signifi ca nt V1 < 0 .05, Wilcoxo n rank sum test). 
N o pos itive o r nega ti ve co rrelation was seen between cutaneous 
ir L Tl3.1 concentrat io ns and disease seve rity, i.e., extent o f discast: 
o r intensity o f inH amm atio n. In addition, no correlation was see n 
between ir L Tl3.1 lcvt: ls and serum lgE concemrat io n . w hich was 
ele vated in 10 of 13 se rum samples. 
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Figure 1. Concentra tions of L TB.1- lik c immuno reactivit y in suction bli s-
ter Auids fro m contro ls, p:Hicnts w ith ato pic dermatiti s and psori asis. 
Concentration s arc shown in pg/ ml. 1-ltJri;:nutn//iuc depi cts the detec tion 
lim it of l l)4 pg/ ml. 1-/tJri::outa/ and i!Crtiral bars show m ea n and SEM, 
n:spccr ivd y. 
In 5 of7 suction b lister Auid sa mples fr o m no nlcsiona l pso riasis 
skin, ir L TB.1 was below detectio n limit . In 2 sa mples, ir L T B4 
concentra ti o ns were 373 and 730 pg/ ml. respectively . In contrast, 
in onl y I of<J sa mples from pso rias is lesio ns, ir L T.l3.1 was below 
the detect ion limit. The remainin g va lues ran ged from 239-1042 
pg/ ml w ith a m ean va lu e of 649 ± 102 pg/ ml. N o correlation 
was o bsc rvt:d in thi s sm all patient g ro up between the t ype of 
pso rias is, ex tent of di sease. and cutaneo us L TB4 concentration. 
The ir L TI3.1 was furth er chara cteri zed b y its chro m atograp h ic 
properties o n re verse-phase 1-IPLC (Fi g 2) . Pooled samples from 
lcs iona l skin of 4 pati em s w ith ato pi c derm atitis were sepa rated 
by HPLC. and immuno reactivity fo r LTl34 was de termined in 1-
ml elu ate fr acti o ns. L TB.1-Iike immunoreactivity was detected 
o nly in fra cti o ns chro m atograp hin g w ith an authenti c L Tl3,1 stan-
dard . thu s exclud in g the poss ibi lit y o f cross-reactions w ith 12-
HETE o r ara chi do ni c ac id . 
Skin Levels of PGEz- and PGDz-Like Immunoreactivity 
(Table I) . Suctio n b liste rs fron1 antecubital skin o f normal con-
tro ls contain ed 12.9 ± 3.7 ng/ ml of PG E:!-Iikc immun o reactivity. 
The va lues fo r abdo mina l skin were 17.5 ± 3 .3 ng/ ml VJ > 0 .05). 
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Figure 2. Hcve rsc-pluse HPLC separation of pooled suctio n blister Auid 
sa mples from invo lved atopic dermatiti s skin . E lu tion prof1k o f LT B,-
Iik e inu11uno reactivity m easured as inhibition of bindin g between L TB,-
antibod y and authentic LTII.1 is shown. ir LTI3.1 shows identica l re tention 
t ime :~ s a LTl3., s t :~ n da rd . fl rrnu•s show pos itio n of L T standards. 
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Table I. Concentrations of PREz-Like Immu noreactivity 
(mean ± SEM) in Suction B lis ter Fluids 
PGE2 
Concentration 
Patient Group (ng/ ml) 
Controls 
Forea rm 12.85 ± 3.72 
Abdomen 17.47 ± 3.30 
Atopic dermatitis 
Lcs ional skin 7.28 ± 2.98 
Unaffected skin 13.01 ± 3.64 
Psoriasis 
Lcsional skin 9. 48 ± 1.39 
Unaffected skin 15.2 1 ± 4.91 
Les iona l ato pi c de rm a titis skin contained 7.3 ± 3 .0 ng / ml o fPGE2 
w h e reas in unin volved skin , 13 .0 ± 3.6 ng/ ml were fo und. The 
co rres po ndin g va lu es fo r invo lved and unin volved psoriasis ~~ in 
were 9.5 ± 1.4 and 15.2 ± 4.9 ng/ml. respecti vely . The d Jftcr-
e n ccs between all th ese values were statis ti call y no t sig nifi ca nt. 
Even th o ug h exogeno usly added PGD2 could be detected in blis te r 
Ru id a fter incubatio n at alka line pH 11 31 (detectio n limit 360 pg). 
no PGD, was found in an y o f the sa mples ana lyzed usin g a ra-
d io immL;noassay for a stable deg radatio n produ ct of PGD2 fo rmed 
under s uch conditio ns . 
Histamine Skin Levels (Table II) Hi sta min e levels in suctio n 
b li s ter Auid fro m hea lthy contro ls were 3. 11 ± 0.48 ng/ ml o n 
the forearm and 2.25 ± 0 .20 o n the abdo m en (diffe rence no t 
signifi cant) . Lesio nal atopi c der m atiti s skin co ntain ed 2.7 1 _± 0 .59 
ng/m l histamine, the co rrespo ndin g va lues in un affected skm were 
2.66 ± 0.23. Lcs io nal and no nl es10nal pso n at1 c skm contamed 
2.32 ± 0 .23 and 2.98 ± 0.46 ng/ ml histamin e, respecti vely. N o ne 
of the differen ces was statis ti ca ll y sig nifi cant. 
DISCUSS IO N 
In an attempt to elu cid ate biochemical events underl y in g cuta-
neous inA ammatio n in atopic dermati t is, we m easu red sucti o n 
b lis ter concentratio ns of several potent m ediators of inAamm a-
tion, includin g L TB . ., PGE2, PGD2, and histamine. Skin of health y 
contro ls contain ed no m eas urab le o r very low levels o f 1r LTB4, 
a 5-lipoxygenasc m eta bo lite of arachid o ni c acid. Similar res ults 
were o btain ed in unin vo lved skin o f subj ects sufferin g from ato pi c 
dermatiti s . In striking contras t , ele va ted levels o f L TB4-Iike im-
mu n o rea cti v ity were~ detected in lcsio nal skin of these patients. 
T he ir m agnitude did no r co rrelate w ith clinica l disease seventy 
o r serum lgE concentratio ns. On the othe r hand , arachidoniC aCJ d 
meta bo lites fo rm ed via the competin g cyclooxygcnase path w ay 
were fou nd in no rmal levels in atopi c derm at itis skin : PGE2 co n-
centratio ns were alm os t identi ca l in all g ro ups studied, and PGD2 
Table II. Histamine Concentratio ns (m ean ± SEM ) in 
Sucti o n B lis ter Flui ds 
Histamin e Concentration 
Patient Group (ng/ m1) 
Controls 
Forea rm 3. II ± (l. ~ R 
Abdomen 2.25 ± 0.20 
Atopic derm atitis 
0.59 Lcsional skin 2.7 1 ± 
Unaffected skin 2.(>6 ± 0.23 
Psori as is 
Lcsional skin 2.32 ± 0.23 
Un affected skin 2.9fl ± 0.-16 
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was undetectable. Similar results w ere o btained in a second g roup 
o f patients sufferin g fro m pso rias is. Uninvo lved psoriatic skin 
contain ed no or o nl y sli g htl y elevated levels ofir L Tl34. In lesional 
pso ria sis skin , levels of ir L TB4 were fo und wh ich even exceeded 
th ose m eas ured in atop ic derm atitis skin . N o correlati on w as seen 
between the type of pso rias is and ir L TB4 con centrations. In 
pso ri as is. too , PGD2 was no t detectable and PGE2 was within 
no rm al limits. 
Histamin e con centratio ns were no t elevated in any of the con-
ditio ns examined. 
O ur fi ndin gs fit well w ith the therapeuti c effi ciency of g lu-
coco rti costeroids in both atopic derm atiti s and pso ria sis, since 
th ese dru gs at leas t in v itro inhibit the fo rmation of bo th cyclo-
oxygcnase and lipoxygenasc produ cts . 
O ur results showin g elevated cu taneous levels of L TB.1-Iike 
immuno reactiv it y in lesio nal pso ri as is skin arc in accordance w ith 
find in gs of Brain ct al f1 7 l and G rabbe ct al [1 8]. w ho were the 
first to dem o nstrate elentcd L TB.1 levels in psoriatic plagu es usin g 
different m ethodo logy . T hi s ph eno m eno n , however, seem s no t 
to be specifi c fo r psori as is , sin ce eleva ted levels could now be 
show n in ato pi c derm atitis skin as well. T hese findin gs coul d 
have impo rta nt pathogenetic impli cat ions . Al tho ugh L TB.1 is known 
as a p redo min ant che m oattractant of neutro phil and eosino phil 
g ranul ocy tes, its to pica l appli cat io n in hum an skin led o nl y in the 
earl y s ta ges of the reacti o n to derm al and epiderm al neu trophil 
in fi ltrates. w hich la cked furth er charac teris ti cs of the psoriatic 
lesio n . At later rim e po in ts, however, a predo min antl y m o no-
nu clea r infi ltrate was o bse rved , thus po intin g to the poss ible at-
trac tio n of m o no nuclear cell s in to :Ho pic derm atitis skin by L TB4 
11 9 1. 
T he L TB.1-derived che m o tac ti c activity fo r m o no nuclea r cells 
in no rm al skin mi g ht be further cnh an ed in ato pi c derm atiti s. 
The ime res t in g o bservati o ns of z:m1 etzki 1201 showed in creased 
m o nocy te sensiti v ity to the chemotactic actio n o fL TB4 in patien ts 
w ith atopic dermatitis and pso ri as is. T his m echan is m co uld con fer 
selecti vity for m o no nu clea r ce lls to L TB4-deri ved che m o tactic 
sig nals and thus co ntri bute to th e predo m inant accumul at io n of 
m o no nu clear cells in atopic derm atitis skin. Sin ce mononu clea r 
ce ll s them selves seem the m os t likely cellular so urce o f L TB4 in 
dermis 12 11 (a ltho ug h its prod uctio n b y kc ratinocytes cann o t be 
exclu ded fro m our results), a self- perpetuatin g amplifi catio n ci rcle 
o f m acrophages prod ucin g L TB4 and th us attracting further m ac-
ro pha gcs in to the inflammatory skin site could be operative in 
atopic de rm atitis . T he lack of specifi city o f elevated L TB4-levcls 
in va rio us inA amm ato ry derma tosc~ such as ato p ic de rm atitis and 
pso ria sis (and as recentl y repo rted, also in allerg ic con ta ct der-
m atitis 1221) is no t surp risin g and docs no r, in o ur o pinio n, lessen 
their pathoge netic implica tio ns. T he biochemi ca l events occurrin g 
in infl ammatory lesio ns in all these dermatoses might well be 
guite similar in view of the un ifo rm therapeuric effi ciency o f 
g lu cocorti cos tcroids in these di sc:1ses wh ich m ay furt her impli-
ca te, but docs no r p rove, an in vo lvem en t of th e arachido ni c ac id 
cascade. Additio nal fac to rs umelatcd to fi nd ings reported here 
sho ul d account fo r the different clin ica l d isease exp ressio ns . His-
ta min e. however, cc: m s to assume a min o r ro le, if an y. in th e 
path ogenesis of inflammatio n in ato pi c derm atitis. 
T he no rma l va lues m eas ured in ~ u c t i o n blister Auid arc in ac-
cOJ·dancc w ith o ur recent repo rt o n no rm al h istamine levels in 
bio psi es o btained ti·o m atop ic derm atiti s sk in . Hi g hl y eleva ted 
hi sta m ine levels were fo un d o nl y in a pati ent su fferin g fro m the 
hypcr-l gE syndro m e [23 1. Previo usly, however, eleva ted levels 
of hi sta m ine we re fo un d in atopic derm atitis skin using less spe-
cifi c m ethods 1241. In p revio us studies fro m o ur g ro u p, in creased 
plas m a leve ls ofhista minc were fo un d in ato pic dermatitis patients 
d urin g acute disease s ta ges, returnin g to no rm al du ring remissio n 
125 1. 
Recentl y, th e g ucstion was raised as to w hether elevated leve ls 
o fL TB4-Iikc immuno reacti vity in suctio n blis ter Auid represented 
true LTl3 4 or could be p:~rrl y due to cross-reactio n wi th ara chi-
doni c acid o r its 12-lipoxygenasc m etabo lite, 12-I-IETE 126], which 
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we n: fo und in lcsio na l pso riati c s k in b y Hammars tro m et a! lSI. 
T hi s ex p lan ati o n see m s unlik ely fo r seve ra l reason s . A ft c r sepa-
rati o n o f poo led samples o f s u cti o n bli s ter Au id s fro m a to pi c 
d e rmatiti s patients b y rcv n se- p h asc HPLC, L TB.,-lik c immu-
n o reacti v ity coch ro m atog raphe d w ith an :~ uthenti c L TB,, s tan -
d ard. Furthe rm o re, t he an ti-L TB., antibo d ies used c ross-react o n ly 
to a s m a ll e x te nt with a rachido ni c acid and 12-HETE 11 4 1. T hu s, 
ve r y hi g h co n cen t ra tion s o f th ese co mpo n en ts mus t be present 
to s ig nifi ca ntly inte rfe re w ith t h e L Tl3.1 radio immun oassay . S u ch 
hi g h co n centratio n s, however, sh o uld also ca use c ross-reac ti o n 
in the radio im mu n oassa ys fo r PC E " an d PC D ", w hi c h w as n o t 
o bse rved. 
Fina ll y, ch e m o tac t ic b io lo g ic ac t ivity w hi ch can now b e as-
sum ed to b e du e to L Tl3.1 w as recove red fro m affected , but n o t 
un a ffe c ted a to p ic d e rmatiti s s kin b y Dic rks m c ic r e t a l 1271. 
In summ a r y. ele v ated levels o f L TB.1-li ke immuno rea ctivity 
w e re id entified in affec ted ato pi c d e rm atit is sk in, w h ich m ig ht be 
o f centra l im p o rtan ce in th e pathogen es is o f the di sease in v ie w 
o f th e potent pro inA a mmatory ac t iv ities of thi s m ediato r a n d t h e 
an ti-inAamm ato r y e ffi c ie ncy o f g lu coco r t icos te ro ids ac tin g as 
poss ible inhibito rs of L TB., s ynth es is . Du e to th e lack o f s pec ifi c it y 
o f these dru gs' act io n s, h owever , furt her c lar ifi cation o f the ro le 
o f L TB.1 in the pathogenesis of cu taneo u s inAamm ation mus t 
await th e av ai lab ili t y o f m o re selective inhi bitors o f L T 13.1 syn-
thesi s o r fu n c tio nal L TB., an ta gonis ts . 
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